Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-13 10:37 am Purchase | 2024-05-02 | 13G | Context Therapeutics Inc. CNTX | Avidity Partners Management LP | 7,776,296 9.900% | 7,776,296 (New Position) | Filing History |
| 2024-05-10 4:00 pm Purchase | 2024-05-02 | 13G | Context Therapeutics Inc. CNTX | Deep Track Capital, LP | 7,419,355 9.890% | 7,419,355 (New Position) | Filing History |
| 2024-02-13 4:45 pm Sale | 2023-12-31 | 13G | Context Therapeutics Inc. CNTX | Affinity Asset Advisors, LLC | 328,817 2.060% | -554,837 (-62.79%) | Filing History |
| 2024-02-07 4:24 pm Purchase | 2023-12-31 | 13G | Context Therapeutics Inc. CNTX | Lehr Martin A. | 1,452,466 8.800% | 1,452,466 (New Position) | Filing History |
| 2024-01-05 4:05 pm Purchase | 2023-12-27 | 13G | Context Therapeutics Inc. CNTX | Opaleye Management Inc. | 820,000 5.140% | 820,000 (New Position) | Filing History |
| 2023-02-14 4:03 pm Purchase | 2022-12-31 | 13G | Context Therapeutics Inc. CNTX | Context Therapeutics Inc. CNTX | 1,186,102 7.300% | 1,186,102 (New Position) | Filing History |
| 2023-01-10 2:47 pm Sale | 2022-12-31 | 13G | Context Therapeutics Inc. CNTX | SABBY MANAGEMENT, LLC | 796,706 11.000% | -434,124 (-35.27%) | Filing History |
| 2023-01-09 5:05 pm Sale | 2023-01-09 | 13G | Context Therapeutics Inc. CNTX | Orin Hirschman | 0 0.000% | -1,285,771 (Position Closed) | Filing History |
| 2022-10-27 1:22 pm Purchase | 2022-01-06 | 13G | Context Therapeutics Inc. CNTX | Orin Hirschman | 1,285,771 8.100% | 1,285,771 (New Position) | Filing History |
| 2022-05-09 5:11 pm Purchase | 2022-04-28 | 13G | Context Therapeutics Inc. CNTX | Affinity Asset Advisors, LLC | 883,654 5.530% | 883,654 (New Position) | Filing History |
| 2022-02-02 4:54 pm Purchase | 2021-12-31 | 13G | Context Therapeutics Inc. CNTX | Hudson Bay Capital Management LP | 1,000,000 8.360% | 1,000,000 (New Position) | Filing History |
| 2022-01-04 9:13 pm Purchase | 2021-12-31 | 13G | Context Therapeutics Inc. CNTX | SABBY MANAGEMENT, LLC | 1,230,830 11.000% | 230,830 (+23.08%) | Filing History |
| 2021-12-06 5:11 pm Purchase | 2021-12-02 | 13G | Context Therapeutics Inc. CNTX | SABBY MANAGEMENT, LLC | 1,000,000 11.000% | 1,000,000 (New Position) | Filing History |